Has Dr Alex Wodak provided any information or opinion on the Therapeutic Goods Administration’s policy relating to Dr George O’Neil or his naltrexone clinic or naltrexone therapy in general; if so, what was the content of that information or opinion and how has it affected Government policy or decision-making relating to funding for Dr O’Neil’s clinic.

A search of departmental correspondence records show that neither the Department of Health and Ageing, National Health and Medical Research Council (NHMRC) or the Therapeutic Goods Administration (TGA) have received any information or opinion from Dr Alex Wodak about Dr George O’Neil, his naltrexone clinics or naltrexone therapy in general.